arrow
F

Federica Borea

humanitas cancer center
H指数:10
被引数:226

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Dynamic Evaluation Of The Glycolytic Determinants LDH-A And GLUT-1 Enhances Prognostic Significance And Their Inhibition Affect The Growth Of Mesothelioma Spheroids

动态评估糖酵解决定因子LDH-A和GLUT-1可增强其预后意义,且它们的抑制影响间皮瘤球体的生长

2026-03-230
OAAI
Perioperative Treatments in Pleural Mesothelioma: State of the Art and Future Directions

Cecchi, L.G.; Aliprandi, M.; De Vincenzo, F.; Perrino, M.; Cordua, N.; Borea, F.; Bertocchi, A.; Federico, A.; Marulli, G.; Santoro, A.; 等. 胸膜间皮瘤的围手术期治疗:现状与未来方向. Cancers 2025, 17, 3199. [Google Scholar] [CrossRef]

Cancers
IF4.4
2026-03-030
OAAI
Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)

ramucirumab联合卡铂和紫杉醇治疗未治疗的转移性胸腺癌的疗效和安全性: RELEVENT II期试验 (NCT03921671)

2024-09-012
OA
Autoimmunity in thymic epithelial tumors: a not yet clarified pathologic paradigm associated with several unmet clinical needs
2024-04-022
OAAI
SARS-CoV-2 vaccine in patients with thymic epithelial tumours with and without active or pre-existing autoimmune disorders: Brief report of a TYME network safety analysis
2022-05-014
OAAI